Skip to main content
SpringerLink
Log in

Endoscopic and Pharmacologic Management of Upper GI Bleeding

  • Living reference work entry
  • First Online:
Oncologic Critical Care

  • 249 Accesses

Abstract

Upper gastrointestinal bleeding can occur from multiple sources. Broadly, upper gastrointestinal bleeding can be divided into variceal and nonvariceal etiologies. The suspected source of bleeding will drive the initial resuscitation and management. Adequate resuscitation, management of the patients prior medications, initiating medications to affect gastric pH, initiating vasoactive drugs, or administering antibiotics all occur prior to endoscopy. Endoscopy is important in the diagnosis and management of upper gastrointestinal bleeding. Pharmacologic agents are useful during the endoscopy to help achieve hemostasis. Finally, once hemostasis is achieved, decisions must be made regarding reinitiation of previous mediations like antithrombotics and which medications can be used acutely and chronically to reduce the risk of rebleeding and mortality from upper gastrointestinal bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. ASGE Standards of Practice Committee, Acosta RD, Abraham NS, Chandrasekhara V, Chathadi KV, Early DS, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83(1):3–16. https://doi.org/10.1016/j.gie.2015.09.035.

    Article  Google Scholar 

  2. ASGE Technology Committee, Bhat YM, Banerjee S, Barth BA, Chauhan SS, Gottlieb KT, et al. Tissue adhesives: cyanoacrylate glue and fibrin sealant. Gastrointest Endosc. 2013;78(2):209–15. https://doi.org/10.1016/j.gie.2013.04.166.

    Article  Google Scholar 

  3. Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, et al. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol. 2010;105(1):106–13. https://doi.org/10.1038/ajg.2009.615.

    Article  PubMed  Google Scholar 

  4. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2008a;103(11):2890–907. https://doi.org/10.1111/j.1572-0241.2008.02216.x.

    Article  CAS  PubMed  Google Scholar 

  5. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical expert consensus documents. J Am Coll Cardiol. 2008b;52(18):1502–17. https://doi.org/10.1016/j.jacc.2008.08.002.

    Article  PubMed  Google Scholar 

  6. Cheung KS, Leung WK. Gastrointestinal bleeding in patients on novel oral anticoagulants: risk, prevention and management. World J Gastroenterol. 2017;23(11):1954–63. https://doi.org/10.3748/wjg.v23.i11.1954.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131–41. https://doi.org/10.1056/NEJMoa1607887.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Ther Adv Gastroenterol. 2014;7(5):206–16. https://doi.org/10.1177/1756283X14538688.

    Article  Google Scholar 

  9. Derogar M, Sandblom G, Lundell L, Orsini N, Bottai M, Lu Y, et al. Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol. 2013;11(1):38–42. https://doi.org/10.1016/j.cgh.2012.08.034.

    Article  CAS  PubMed  Google Scholar 

  10. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology/diagnosis/management. Philadelphia: Saunders/Elsevier; 2016.

    Google Scholar 

  11. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–35. https://doi.org/10.1002/hep.28906.

    Article  Google Scholar 

  12. Ghassemi KA, Kovacs TO, Jensen DM. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage. Curr Gastroenterol Rep. 2009;11(6):462–9. https://www.ncbi.nlm.nih.gov/pubmed/19903422.

    Article  Google Scholar 

  13. Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2015;47(10):a1–46. https://doi.org/10.1055/s-0034-1393172.

    Article  PubMed  Google Scholar 

  14. Harrison MF. The misunderstood coagulopathy of liver disease: a review for the acute setting. West J Emerg Med. 2018;19(5):863–71. https://doi.org/10.5811/westjem.2018.7.37893.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hwang JH, Fisher DA, Ben-Menachem T, Chandrasekhara V, Chathadi K, Decker GA, et al. The role of endoscopy in the management of acute non-variceal upper GI bleeding. Gastrointest Endosc. 2012;75(6):1132–8. https://doi.org/10.1016/j.gie.2012.02.033.

    Article  PubMed  Google Scholar 

  16. Hwang JH, Shergill AK, Acosta RD, Chandrasekhara V, Chathadi KV, Decker GA, et al. The role of endoscopy in the management of variceal hemorrhage. Gastrointest Endosc. 2014;80(2):221–7. https://doi.org/10.1016/j.gie.2013.07.023.

    Article  PubMed  Google Scholar 

  17. Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Ann Intern Med. 1997;127(12):1062–71. https://www.ncbi.nlm.nih.gov/pubmed/9412308

    Article  CAS  Google Scholar 

  18. Kang SH, Yim HJ, Kim SY, Suh SJ, Hyun JJ, Jung SW, et al. Proton pump inhibitor therapy is associated with reduction of early bleeding risk after prophylactic endoscopic variceal band ligation: a retrospective cohort study. Medicine (Baltimore). 2016;95(8):e2903. https://doi.org/10.1097/MD.0000000000002903.

    Article  CAS  Google Scholar 

  19. Kim BS, Li BT, Engel A, Samra JS, Clarke S, Norton ID, et al. Diagnosis of gastrointestinal bleeding: a practical guide for clinicians. World J Gastrointest Pathophysiol. 2014;5(4):467–78. https://doi.org/10.4291/wjgp.v5.i4.467.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol. 2012;107(3):345–60; quiz 361. https://doi.org/10.1038/ajg.2011.480.

    Article  CAS  PubMed  Google Scholar 

  21. Lo GH, Perng DS, Chang CY, Tai CM, Wang HM, Lin HC. Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding. J Gastroenterol Hepatol. 2013;28(4):684–9. https://doi.org/10.1111/jgh.12107.

    Article  CAS  PubMed  Google Scholar 

  22. Lo EA, Wilby KJ, Ensom MH. Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review. Ann Pharmacother. 2015;49(2):207–19. https://doi.org/10.1177/1060028014559244.

    Article  CAS  PubMed  Google Scholar 

  23. Lu Y, Loffroy R, Lau JY, Barkun A. Multidisciplinary management strategies for acute non-variceal upper gastrointestinal bleeding. Br J Surg. 2014;101(1):e34–50. https://doi.org/10.1002/bjs.9351.

    Article  CAS  PubMed  Google Scholar 

  24. Lu Y, Adam V, Teich V, Barkun A. Timing or dosing of intravenous proton pump inhibitors in acute upper gastrointestinal bleeding has low impact on costs. Am J Gastroenterol. 2016;111(10):1389–98. https://doi.org/10.1038/ajg.2016.157.

    Article  CAS  PubMed  Google Scholar 

  25. Muguruma N, Kitamura S, Kimura T, Miyamoto H, Takayama T. Endoscopic management of nonvariceal upper gastrointestinal bleeding: state of the art. Clin Endosc. 2015;48(2):96–101. https://doi.org/10.5946/ce.2015.48.2.96.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Oakland K, Desborough MJ, Murphy MF, Schachter M, Jairath, V. Re-bleeding and mortality after lower gastrointestinal bleeding in patients taking anti-platelets or anti-coagulants. Clin Gastroenterol Hepatol. 2017. https://doi.org/10.1016/j.cgh.2017.12.032.

    Article  Google Scholar 

  27. Oakland K, Jairath V, Murphy MF. Advances in transfusion medicine: gastrointestinal bleeding. Transfus Med. 2018;28(2):132–9. https://doi.org/10.1111/tme.12446.

    Article  CAS  PubMed  Google Scholar 

  28. Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, et al. Idarucizumab for dabigatran reversal. N Engl J Med. 2015;373(6):511–20. https://doi.org/10.1056/NEJMoa1502000.

    Article  CAS  Google Scholar 

  29. Robertson M, Majumdar A, Boyapati R, Chung W, Worland T, Terbah R, et al. Risk stratification in acute upper GI bleeding: comparison of the AIMS65 score with the Glasgow-Blatchford and Rockall scoring systems. Gastrointest Endosc. 2016;83(6):1151–60. https://doi.org/10.1016/j.gie.2015.10.021.

    Article  PubMed  Google Scholar 

  30. Shim CN, Chung HS, Park JC, Shin SK, Lee SK, Lee YC, et al. Is endoscopic therapy safe for upper gastrointestinal bleeding in anticoagulated patients with supratherapeutic international normalized ratios? Am J Ther. 2016;23(4):e995–e1003. https://doi.org/10.1097/MJT.0000000000000002.

    Article  PubMed  Google Scholar 

  31. Shingina A, Barkun AN, Razzaghi A, Martel M, Bardou M, Gralnek I, et al. Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding. Aliment Pharmacol Ther. 2011;33(9):1010–8. https://doi.org/10.1111/j.1365-2036.2011.04618.x.

    Article  CAS  PubMed  Google Scholar 

  32. Short NJ, Connors JM. New oral anticoagulants and the cancer patient. Oncologist. 2014;19(1):82–93. https://doi.org/10.1634/theoncologist.2013-0239.

    Article  CAS  PubMed  Google Scholar 

  33. Strate LL, Gralnek IM. ACG clinical guideline: management of patients with acute lower gastrointestinal bleeding. Am J Gastroenterol. 2016;111(5):755. https://doi.org/10.1038/ajg.2016.155.

    Article  PubMed  Google Scholar 

  34. Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–704. https://doi.org/10.1136/gutjnl-2015-309262.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Udayachalerm S, Rattanasiri S, Angkananard T, Attia J, Sansanayudh N, Thakkinstian A. The reversal of bleeding caused by new oral anticoagulants (NOACs): a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2018. https://doi.org/10.1177/1076029618796339.

    Article  CAS  Google Scholar 

  36. Villanueva C, Colomo A, Bosch A, Concepcion M, Hernandez-Gea V, Aracil C, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21. https://doi.org/10.1056/NEJMoa1211801.

    Article  CAS  Google Scholar 

  37. Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, et al. Safe use of proton pump inhibitors in patients with cirrhosis. Br J Clin Pharmacol. 2018;84(8):1806–20. https://doi.org/10.1111/bcp.13615.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286–93. https://doi.org/10.1007/s10620-017-4882-6.

    Article  PubMed  Google Scholar 

  39. Zakko L, Rustagi T, Douglas M, Laine L. No benefit from platelet transfusion for gastrointestinal bleeding in patients taking antiplatelet agents. Clin Gastroenterol Hepatol. 2017;15(1):46–52. https://doi.org/10.1016/j.cgh.2016.07.017.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Anesthesiology, Critical Care & Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Sajini Thekkel

  2. Department of Gastroenterology, Hepatology & Nutrition, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    David Richards & William Ross

Authors
  1. David Richards
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sajini Thekkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Richards .

Editor information

Editors and Affiliations

  1. Department of Critical Care, University of Texas MD Anderson Cancer C Department of Critical Care, Houston, TX, USA

    Joseph L. Nates

  2. Department of Critical Care, University of Texas MD Anderson Cancer C Department of Critical Care, Houston, TX, USA

    Kristen J. Price

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Richards, D., Thekkel, S., Ross, W. (2019). Endoscopic and Pharmacologic Management of Upper GI Bleeding. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74698-2_176-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74698-2_176-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74698-2

  • Online ISBN: 978-3-319-74698-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation